Ultime notizie per Davis Commodities (NASDAQ:DTCK) Azioni

Davis Commodities

Davis Commodities Ltd is an agricultural commodity trading company based in Singapore which specializes in trading of three main categories of agricultural commodities namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.

Davis Commodities Limited - Ordinary Shares

Davis Commodities Ltd

Perimeter Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRM#NYSE">PRM</a>) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.23 by 86.96 percent. This is a 105.26 percent increase over losses of $(0.57) per share from the same period last year. The company reported quarterly sales of $72.03 million which missed the analyst consensus estimate of $105.31 million by 31.60 percent. This is a 21.99 percent increase over sales of $59.04 million the same period last year.

Earnings

Earnings Misses

News

Perimeter Solutions Q1 Adj. EPS $0.03 Misses $0.23 Estimate, Sales $72.03M Miss $105.31M Estimate

<a href="https://x.com/BaiduApollo/status/1920415399671116065" title="https://x.com/BaiduApollo/status/1920415399671116065">https://x.com/BaiduApollo/status/1920415399671116065</a>

Tech

BIDU

Baidu Apollo In X Post, Announced Strategic Partnership With CAR Inc. To Launch World's First Autonomous Vehicle Rental Service

General

BCE And Public Sector Pension Investment Board Formed Network Fiberco, A Long-term Strategic Partnership To Accelerate The Development Of Fibre Infrastructure Through Ziply Fiber, In Underserved Markets In The United States

Needham analyst Scott Berg reiterates CS Disco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAW#NYSE">LAW</a>) with a Buy and maintains $8 price target.

Price Target

Reiteration

Analyst Ratings

Needham Reiterates Buy on CS Disco, Maintains $8 Price Target

Haemonetics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAE#NYSE">HAE</a>) is looking for FY2026 Adj EPS of $4.70-$5.00 vs $4.93 analyst estimate..

Guidance

Haemonetics Sees FY2026 Adj EPS $4.70-$5.00 vs $4.93 Est

Infineon Technologies (OTC:<a class="ticker" href="https://www.benzinga.com/stock/IFNNY#OTC">IFNNY</a>) sees Q3 sales of $4.163 billion vs $3.86 billion analyst estimate.

IFNNY

Infineon Technologies Sees Q3 Sales $4.163B vs $3.86B Est

Needham analyst Laura Martin reiterates Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) with a Buy and maintains $125 price target.

Needham Reiterates Buy on Walt Disney, Maintains $125 Price Target

GLISTEN met the primary endpoint of change from baseline in monthly itch score and showed linerixibat (n=119) significantly improved itch versus placebo (n=119) over 24-weeks, as measured on a 0-10 numerical rating scale (NRS) for the worst itch (WI-NRS) (least squares [LS] mean difference [95% CI]: -0.72 [-1.15, -0.28], p=0.001). Monthly itch score evaluated the worst weekly itch of each month over the 24-week treatment period. This finding supports linerixibat's potential to address a major symptom of PBC, relentless itch.
&nbsp;
The trial also met key secondary endpoints including itch score at week 2 and itch-related sleep interference NRS over 24 weeks demonstrating:
·&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Improvement in itch was rapid with a significant improvement over placebo at week 2 (LS mean difference [95% CI]: -0.71 [-1.07, -0.34], p&lt;0.001) and sustained throughout the trial.
·&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Significant improvement in itch-related sleep interference, which impacts patient quality of life, over 24 weeks of treatment with linerixibat compared with placebo (LS mean difference [95% CI]: -0.53 [-0.98, -0.07], p=0.024).
·&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;More patients in the linerixibat group had clinically meaningful itch improvement (WI-NRS ≥3-point reduction) with 56% versus 43% in the placebo group at week 24 (treatment difference 13% [95% CI 0%-27%], nominal p=0.043).
&nbsp;
Kaivan Khavandi, SVP, Global Head, Respiratory, Immunology &amp; Inflammation R&amp;D, GSK, said: "Relentless itch is present in the majority of patients with PBC and is a symptom that affects sleep, mental health, and quality of life. With linerixibat, we are one step closer to addressing the high unmet need of itch and its related sleep interference that are critically important to patients but historically under-treated."
&nbsp;
The safety profile of linerixibat was consistent with previous studies and the mechanism of IBAT inhibition, with gastrointestinal side-effects more common in the active treatment group. The most common adverse event, diarrhoea, was mostly mild in intensity; discontinuation due to diarrhoea was 4% in the linerixibat group versus &lt;1% in the placebo group.
&nbsp;
Gideon Hirschfield, Lily and Terry Horner Chair in Autoimmune Liver Disease Research, Director of the Autoimmune and Rare Liver Disease Programme at University Health Network, Toronto and lead author of the GLISTEN study, said: "Currently there are very limited therapies for pruritus in PBC and previous attempts to develop new therapies have been unsuccessful. As an investigator who also sees many patients with PBC, and who has worked with this molecule from the early phase II studies, the clear improvements in itch and its related sleep interference seen in GLISTEN are meaningful and clinically important."
&nbsp;
Linerixibat is currently not approved anywhere in the world.

Biotech

Large Cap

Health Care

GSK Announced Results From GLISTEN Phase 3 Trial Of Linerixibat In Adults With Cholestatic Pruritus And PBC, A Rare Autoimmune Liver Disease. The Full Data Were Presented In A Late-breaker Oral Presentation At The EASL Congress 2025

Needham analyst Chris Pierce reiterates Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) with a Buy and maintains $340 price target.

CVNA

Needham Reiterates Buy on Carvana, Maintains $340 Price Target

Sapiens International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) raises FY2025 sales outlook from $553.00 million-$558.00 million to $574.00 million-$578.00 million.

SPNS

Sapiens International Raises FY2025 Sales Guidance from $553.00M-$558.00M to $574.00M-$578.00M

Wolverine World Wide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WWW#NYSE">WWW</a>) is looking for Q2 GAAP EPS of $0.17-$0.22 vs $0.26 analyst estimate..

Wolverine World Wide Sees Q2 GAAP EPS $0.17-$0.22 vs $0.26 Est

Wolverine World Wide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WWW#NYSE">WWW</a>) is looking for Q2 Adj EPS of $0.19-$0.24 vs $0.24 analyst estimate. sees sales of $440.000 million-$450.000 million vs $440.37 million analyst estimate.

Wolverine World Wide Sees Q2 Adj EPS $0.19-$0.24 vs $0.24 Est; Sees Sales $440.000M-$450.000M vs $440.37M Est

First Advantage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FA#NASDAQ">FA</a>) affirms FY2025 Adj EPS guidance from $0.86-$1.03 to $0.86-$1.03 vs $0.90 analyst estimate. Affirms FY2025 sales outlook from $1.50 billion-$1.60 billion to $1.50 billion-$1.60 billion vs $1.51 billion estimate.

First Advantage Affirms FY2025 Adj EPS Guidance of $0.86-$1.03 vs $0.90 Est; Affirms FY2025 Sales Guidance of $1.50B-$1.60B vs $1.51B Est

Needham analyst Scott Berg reiterates Dayforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAY#NYSE">DAY</a>) with a Buy and maintains $95 price target.

Needham Reiterates Buy on Dayforce, Maintains $95 Price Target

First Advantage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FA#NASDAQ">FA</a>) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.13 by 30.77 percent. This is unchanged from the same period last year. The company reported quarterly sales of $354.59 million which beat the analyst consensus estimate of $344.34 million by 2.98 percent. This is a 109.30 percent increase over sales of $169.42 million the same period last year.

Earnings Beats

First Advantage Q1 Adj. EPS $0.17 Beats $0.13 Estimate, Sales $354.59M Beat $344.34M Estimate

Wolverine World Wide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WWW#NYSE">WWW</a>) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.11 by 63.64 percent. This is a 260 percent increase over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $412.30 million which beat the analyst consensus estimate of $395.69 million by 4.20 percent. This is a 4.41 percent increase over sales of $394.90 million the same period last year.

Wolverine World Wide Q1 Adj. EPS $0.18 Beats $0.11 Estimate, Sales $412.30M Beat $395.69M Estimate

CORRECTION: Genesis Energy Q1 EPS $(0.60) Down From $(0.15) YoY, Sales $398.31M Down From $434.45M YoY

WestPark Capital analyst Curtis Shauger reiterates Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Buy and maintains $210 price target.

GOOGL

WestPark Capital Reiterates Buy on Alphabet, Maintains $210 Price Target

Sapiens Intl Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.35 by 5.71 percent. This is a 2.78 percent increase over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $136.10 million which missed the analyst consensus estimate of $136.25 million by 0.11 percent. This is a 1.38 percent increase over sales of $134.25 million the same period last year.

Sapiens Intl Corp Q1 Adj. EPS $0.37 Beats $0.35 Estimate, Sales $136.10M Miss $136.25M Estimate

U.S. stock futures rose on Thursday after two days of advance on Wednesday. Futures of major benchmark indices were higher in premarket.
This followed the Federal Reserve&#8217;s <a href="https://www.benzinga.com/government/regulations/25/05/45266366/powell-flags-sharp-tariff-shock-elevated-uncertainty-fed-sticks-to-wait-and-see-mode">decision to hold the interest rate</a> steady at 4.25% to 4.5% on Wednesday. 
"The tariff increases announced so far have been significantly larger than anticipated," Fed Chair Jerome Powell said.
He noted that if the tariffs are sustained, they could lead to higher inflation, weaker growth, and a rise in unemployment, directly undermining the Fed&#8217;s dual mandate.
"We don&#8217;t think we need to be in a hurry. We are going to be watching the data. It may move quickly or slowly. But we&#8217;re well-positioned to wait," he said.
Meanwhile, the 10-year Treasury bond yielded 4.31% and the two-year bond was at 3.82%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing a 79.8% likelihood of the Federal Reserve keeping the current interest rates unchanged in its June meeting.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.72%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.94%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>1.38%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1.31%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose in premarket on Thursday. The SPY was up 1.14% to $567.54, while the QQQ advanced 1.51% to $490.61, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Leading the gains among sectors in the S&amp;P 500 on Wednesday were health care, consumer discretionary, and information technology stocks, as most sectors closed positively.
Bucking this trend were communication services and materials stocks, which finished the session lower.
In company news, Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) reported first-quarter revenue that fell short of expectations, while Walt Disney Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) announced positive fiscal second-quarter 2025 results on Wednesday.
On the economic front, U.S. mortgage application volumes saw an 11% increase from the prior week for the week ending May 2nd.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.27%</td>
<td>17,738.16</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.43%</td>
<td>5,631.28</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.70%</td>
<td>41,113.97</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.33%</td>
<td>1,989.66</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Sharing a<a href="https://www.benzinga.com/general/market-summary/25/05/45278334/sp-500-chart-indicates-adding-long-positions-as-expert-says-market-has-found-its-balance?utm_campaign=Watchlist&amp;utm_source=Benzinga&amp;utm_medium=Email"> 10-year S&amp;P 500 chart</a> on X, Jurrien Timmer, Director of Global Macro at Fidelity Investments, offered a simple yet thought-provoking approach to navigating uncertainty.
He suggested considering whether to take a long or short position based on the index&#8217;s historical performance. Analyzing the technical patterns, Timmer concluded that establishing or increasing &#8220;long&#8221; positions appeared to be the more favorable strategy.
Timmer stated that the S&amp;P 500 appears to have gravitated back to this long-term uptrend line. This convergence, according to Timmer, suggests that the &#8220;market has found its balance.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">At times of uncertainty, I find it useful to pull up a simple chart of the S&amp;P 500 and ask myself: do I want to be long or short this chart? Different people will come up with different answers, but for me the chart below suggests "long." We have a rising uptrend line and a… <a href="https://t.co/DsLOxYz6sn">pic.twitter.com/DsLOxYz6sn</a>
&mdash; Jurrien Timmer (@TimmerFidelity) <a href="https://twitter.com/TimmerFidelity/status/1920148872690532867?ref_src=twsrc%5Etfw">May 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Scott Wren, the senior global market strategist at Wells Fargo, stated in his weekly note that &#8220;Further near-term upside in the S&amp;P 500 Index is likely limited, and we expect to see more downside volatility before the tariff uncertainties are resolved.&#8221;
According to Wren, central bankers keep telling us they are "data dependent." That means Chair Powell and the other voting Federal Open Market Committee members need to see the data that tells the Federal Reserve the labor environment is weak and/or inflation readings are coming down consistently.
&#8220;In the meantime, we are looking into 2026 and seeing an economic and earnings recovery. For now, while volatility remains the likely headline, we prefer to focus on quality, like large- and mid-cap U.S. equities, and favor the Energy, Communication Services, Information Technology, and Financials sectors,&#8221; he added.
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Thursday:
<ul>
<li>Initial jobless claims for the week ended May 3 and U.S. productivity data for the first quarter will be released by 8:30 a.m. ET.</li>
</ul>
<ul>
<li>March&#8217;s wholesale inventories data will be out by 10:00 a.m. ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>US Foods Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>) fell 0.17% in premarket on Thursday as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of 69 cents per share on revenue of $9.38 billion.</li>
<li>ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) was up 1.35% as Wall Street expects it to report earnings of 50 cents per share on revenue of $11.62 billion before the opening bell.</li>
<li>Coinbase Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) jumped 4.53% as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of 69 cents per share on revenue of $9.38 billion.</li>
<li>Anheuser-Busch Inbev SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>) rose 2.55% after reporting a 7.9% increase in operating profit for the first quarter, also topping market estimates.</li>
<li>Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) dropped 9.31% after posting a wider-than-expected loss for the first quarter after the closing bell on Wednesday. The company also said it expects full-year 2025 steel unit cost reductions of approximately $50 per net ton compared to the prior year.</li>
<li>Digital Ally Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) jumped 64.49% after it received a positive determination from the Nasdaq Hearings Panel regarding its continued listing on the Nasdaq Stock Market.</li>
<li>Costamare Bulkers Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMDB#NYSE">CMDB</a>) zoomed 40.27%, announced today that it has completed the spin-off of its dry bulk business into a standalone public company, Costamare Bulkers Holdings Ltd.</li>
<li>Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) was 0.82% higher after China Airlines announced an order including Boeing 777X passenger and freighter models.</li>
<li>Asset Entities Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) skyrocketed 54.57% after it entered into a definitive merger agreement with Strive Asset Management, a subsidiary of Strive Enterprises, Inc.</li>
<li>Beyond Meat Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYND#NASDAQ">BYND</a>) declined 2.36% after missing analysts&#8217; expectations during the first quarter.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) jumped 4.21% after the company reported better-than-expected results during the first quarter.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 1.10% to hover around $58.71 per barrel.
Gold Spot US Dollar fell 0.77% to hover around $3,338.64 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was higher by 0.45% at the 100.0640 level.
Asian markets ended higher on Wednesday except India's S&amp;P BSE Sensex. On the other hand, Japan's Nikkei 225, Australia's ASX 200, China&#8217;s CSI 300, Hong Kong's Hang Seng, and South Korea's Kospi index rose. European markets were mixed in early trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/05/45251508/warren-buffett-falls-behind-nancy-pelosi-in-stock-market-returns-over-the-last-11-years-heres-what-data-shows">Warren Buffett Falls Behind Nancy Pelosi In Stock Market Returns Over The Last 11 Years: Here&#8217;s What Data Shows</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Market Summary

Futures

Technicals

Treasuries

Economics

Federal Reserve

Pre-Market Outlook

Markets

Trading Ideas

ASST

BYND

CMDB

COIN

DGLY

UBER

USFD

US Stocks Likely To Open Higher After Two Days Of Advance: 'Market Has Found Its Balance,' Says Expert Citing S&P 500's Technical Analysis

Press Releases

First Half of Fiscal Year 2024 Unaudited Financial Results

Contracts

Davis Commodities Limited to Sign USD 15 Million Agarwood Oil Distribution MOU with Dadvance Agarwood Solutions

Financing

Davis Commodities Limited Secures S$10 Million Banking Facility to Fuel Strategic Growth

Davis Commodities Limited Announces USD 2 million AI Operation Enhancement MOU with QBE.AI Limited

Davis Commodities Limited and Kohai Jointly Engage in Strategic AI Investments

Davis Commodities Limited and Carfax Commodities (Asia) Pte Ltd to Enter into Stock Acquisition Plan

Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Davis Commodities Announces Issuance of New Shares Amounting to USD 30 Million

Davis Commodities Announces Strategic Joint Venture with Leading Malaysian Agri-Processor to Capitalize on Regional Policy Shifts and Secure Preferred Market Access

Comments

Davis Commodities

Notizie

Ultime notizie per Davis Commodities (NASDAQ:DTCK) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO